TMCnet News
G1 Therapeutics to Present at H.C. Wainwright Annual Global Investment Conference on September 9, 2019RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that Chief Financial Officer Jennifer Moses will present a company overview at the H.C. Wainwright Annual Global Investment Conference. The presentation will take place on Monday, September 9, 2019 at 9:35 a.m. at the Lotte New York Palace Hotel in New York, NY. To access the live webcast presentation, please visit the Events & Presentations page within the Investors section of the G1 website. The webcast will be archived on the same page for 90 days following the event. About G1 Therapeutics/strong> G1 is based in Research Triangle Park, NC. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics. Contact: |